Target intelligence / Profile preview

CUGBP Elav-like family member 6 (CELF6)

Target
CELF6
Molecular classification
Other (RNA-binding protein, member of the CELF/BRUNOL family)
01

Overview

CUGBP Elav-like family member 6 (CELF6) is a member of the CELF/BRUNOL family of RNA-binding proteins characterized by having three RNA recognition motif (RRM) domains (two N-terminal, one C-terminal) and a divergent domain between the second and third RRM domains[1][2][5][7]. CELF6 is expressed most abundantly in the brain and kidney. It regulates post-transcriptional gene expression, particularly by modulating pre-mRNA alternative splicing, mRNA stability, and translation. In neuronal tissue, CELF6 binds to UGU-rich motifs in the 3’ UTRs of synaptic mRNAs, influencing synaptic protein abundance and neurological function[2][5]. Genetic disruption of CELF6 is implicated in neuropsychiatric disorders, such as autism spectrum disorder, and changes in CELF6 expression have been associated with cancer, where it can act as a tumor suppressor by stabilizing the mRNA of cell cycle regulators such as p21 and influencing pathways like p53[3][4][5]. CELF6 does not currently have known direct pharmacological ligands and is not a recognized therapeutic target for drugs in clinical use.

Other names
BRUNOL6Bruno-like protein 6CUGBP- and ETR-3-like factor 6RNA-binding protein BRUNOL-6bruno-like 6
02

Biological functions

Regulation of alternative splicingmRNA editingmRNA stabilitytranslation regulationcell cycle regulationneuronal development and function
03

Disease associations

Neurodevelopmental disorders (e.g., autism spectrum disorder)Cancer (e.g., tumor suppression, cell proliferation)Myotonic dystrophyOther (broad tissue expression with major functions in the brain and kidney)

Beyond the preview

Go deeper on CUGBP Elav-like family member 6 (CELF6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CUGBP Elav-like family member 6 (CELF6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call